Andrew Willis Bsc

Andrew Willis currently works as an independent consultant providing expert advice and training on global regulatory solutions and pharmaceutical development. Previously, Andrew worked for Catalent Pharma Solutions as VP Regulatory Affairs and Consulting Services. Catalent is the world’s leading contract manufacturer and distributor of pharmaceuticals, and Andrew was head of a team of internal and external regulatory affairs consultants.

Andrew qualified as a Chemist from the University of Glamorgan, after which he furthered his understanding of pharmaceutical development, working as a research chemist with Parke Davis. He has ten years manufacturing and analytical experience prior to entering regulatory affairs as a Senior Executive Officer with responsibility for submission of European MAAs and project management of development programs.

Andrew currently has a total of 28 years pharmaceutical experience with extensive knowledge in the development and manufacture of sterile, solid oral, inhalation, topical and biotech pharmaceutical products. These experiences have allowed knowledge of many biotech products requirements with experiences of growth hormones and multiple cancer treatments, including development and clinical registration of the first genetically modified live bacterium for such treatment.